A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia

Ragy R. Girgis, Jared X. Van Snellenberg, Andrew Glass, Lawrence S. Kegeles, Judy L. Thompson, Melanie Wall, Raymond Y. Cho, Cameron S Carter, Mark Slifstein, Anissa Abi-Dargham, Jeffrey A. Lieberman

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia'. Together they form a unique fingerprint.

Medicine & Life Sciences